The Cancer Research Institute (CRI) has appointed Alicia Zhou, PhD, as its new Chief Executive Officer (CEO).
A Ludwig Cancer Research study has discovered that recurrent tumors of the aggressive brain cancer glioblastoma multiforme (GBM) grow out of the fibrous scars of malignant predecessors destroyed by interventions such as radiotherapy, surgery and immunotherapy.
MSK researchers have identified two signaling pathways that work together to spur the spread of lung cancer. Taking away one of those signals could help slow or stop metastasis, findings in animal models suggest.
CRI is co-hosting CICON24 to illuminate pioneering advances in cancer immunotherapy research starting September 8 in National Harbor, MD.
Ruth D. Stephenson, DO, FACOG, gynecologic oncologist at RWJBarnabas Health and Rutgers Cancer Institute, New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center, addresses five frequently asked questions about ovarian cancer.
Below are summaries of recent Fred Hutch Cancer Center research findings, patient stories and other news.
Immune checkpoint inhibitors are a type of cancer treatment that helps the immune system attack cancer cells more effectively. One of the key proteins involved in this process is Lymphocyte Activation Gene-3 (LAG3), which suppresses the antitumor immune response.
Rutgers Cancer Institute, the state’s only National Cancer Institute-designated Comprehensive Cancer Center together with RWJBarnabas Health, have appointed Jonathan H. Sherman, MD, FAANS, FCNS, FACS as chief of Neurosurgical Oncology at Rutgers Cancer Institute.
Mark Evers, MD, FACS; Kelvin Lee, MD; and Thomas A. Sellers, PhD, MPH, have been elected to the Board of Directors of the Association of American Cancer Institutes (AACI). The new board members will begin their two-year terms in October, during the 2024 AACI/CCAF Annual Meeting in Chicago.
The Association of American Cancer Institutes (AACI) congratulates this year's Distinguished Scientist, Cancer Health Equity, and Champion for Cures award recipients. The awards will be presented on Monday, October 21, during the 2024 AACI/CCAF Annual Meeting in Chicago.
Christopher Amos, PhD, will join The University of New Mexico Comprehensive Cancer Center on October 1, Yolanda Sanchez, PhD, announced. Sanchez leads the UNM Comprehensive Cancer Center as Director and CEO. Amos will serve as Associate Director for Population Sciences and Cancer Control at the UNM Cancer Center and will also serve as Director of the UNM Health Sciences Center (HSC) Data Science Initiative.
New research from Memorial Sloan Kettering Cancer Center (MSK) uses cryo-electron microscopy to shed new light on the ubiquitin; could help predict the risk of blood clots in cancer patients; reveals why micronuclei burst, accelerating aggressive cancers; and surveys healthcare providers about the benefits and risks of commercial genetic testing.
A new study from the Violence Prevention Research Program at UC Davis suggests that gun-free zones may reduce the risk of mass shootings.
Aubyn Stahmer, professor in the Department of Psychiatry and Behavioral Sciences, has been named the new director of the UC Davis MIND Institute.
Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments
David M. Golombos, MD, urologic oncologist in the Urologic Oncology Program at Rutgers Cancer Institute and RWJBarnabas Health, New Jersey’s only NCI-designated Comprehensive Cancer Center, shares what men need to know about prostate cancer and screening.
A Ludwig Cancer Research study has identified a metabolic switch in the immune system’s T cells that is essential to the generation of memory T cells—which confer lasting immunity to previously encountered pathogens—and a T cell subtype found in tumors that drives anti-tumor responses during immunotherapy.
Tens of millions of Americans are being exposed to tobacco content on streaming services, according to new research from The University of Texas MD Anderson Cancer Center.
UC Davis Health researchers has discovered a novel bioelectrical mechanism pathogens like Salmonella use to find entry points in the gut lining that would allow them to pass and cause infection.
The University of Texas MD Anderson Cancer Center today was awarded nine grants totaling over $21.4 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of two new core facilities, faculty recruitment and groundbreaking cancer research across all areas of the institution.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
